Quintin Yang

Quintin Yang has extensive experience in patient safety and medical affairs, currently serving as Patient Safety Associate Medical Director and Real World Evidence Senior Manager at Vertex Pharmaceuticals from September 2021 to February 2025. Notably, Quintin has led epidemiological studies on sickle cell disease and contributed to clinical trial strategies for myotonic dystrophy type 1. Previous roles include Biostatistician II at Beth Israel Deaconess Medical Center, where statistical analyses advanced research on irritable bowel syndrome and celiac disease, and Medical Advisor at GSK, facilitating vaccine launches. Quintin’s earlier career at National Taiwan University Hospital as an attending physician involved establishing specialized clinics and participating in clinical trials. Quintin holds a PhD and MS in Epidemiology from National Taiwan University.